|
SEC22A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.72130000048499E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.97050000000565E-05 |
| Normal-vs-Stage2 |
1.192600E-04 |
| Normal-vs-Stage3 |
3.04589999888805E-08 |
| Normal-vs-Stage4 |
9.36040001064953E-09 |
| Stage1-vs-Stage2 |
2.804400E-01 |
| Stage1-vs-Stage3 |
1.697920E-02 |
| Stage1-vs-Stage4 |
5.480500E-03 |
| Stage2-vs-Stage3 |
5.334400E-01 |
| Stage2-vs-Stage4 |
1.771780E-01 |
| Stage3-vs-Stage4 |
3.138800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.08869999968253E-07 |
| Normal-vs-AfricanAmerican |
2.598800E-03 |
| Normal-vs-Asian |
3.900800E-03 |
| Caucasian-vs-AfricanAmerican |
8.009200E-01 |
| Caucasian-vs-Asian |
4.689500E-02 |
| AfricanAmerican-vs-Asian |
3.455400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.96860000004173E-06 |
| Normal-vs-Female |
1.82220000000122E-06 |
| Male-vs-Female |
8.680800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.758400E-04 |
| Normal-vs-Age(41-60Yrs) |
7.65509999944847E-07 |
| Normal-vs-Age(61-80Yrs) |
9.65580000400479E-08 |
| Normal-vs-Age(81-100Yrs) |
8.935900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.092300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.352130E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.010200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.970200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.646200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.303400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.383400E-04 |
| Classical-VS-Follicular |
6.272200E-01 |
| Classical-VS-Other |
7.796000E-02 |
| Classical-VS-Normal |
3.81050000000105E-05 |
| Tall-VS-Follicular |
1.070470E-02 |
| Tall-VS-Other |
7.318000E-01 |
| Tall-VS-Normal |
1.9538999973534E-08 |
| Follicular-VS-Other |
2.113800E-01 |
| Follicular-VS-Normal |
2.603600E-04 |
| Other-VS-Normal |
8.794600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.14109999996381E-06 |
| Normal-vs-N1 |
9.11889996846327E-09 |
| N0-vs-N1 |
1.966310E-02 |
|
|
